116
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

IL-2 regulates oral mucosa inflammation through inducing endoplasmic reticulum stress and activating the NF-ĸB pathway

&
Pages 187-193 | Received 17 Jan 2020, Accepted 31 Jan 2020, Published online: 14 Feb 2020
 

Abstract

Objective: The molecular mechanism underlying oral mucosa inflammation remains unknown.

Aim: The aim of our study is to explore the influence of interleukin-2 (IL-2) in regulating oral mucosa viability and inflammation response.

Methods: Oral mucosa epithelium was treated with IL-2. Cell viability and death were determined via 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromidefo (MTT) assay and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, respectively. Inflammation response was measured via enzyme-linked immunosorbent assay (ELISA), and quantitative polymerase chain reaction (qPCR). Western blot and immunofluorescence were used to verify the alterations of nuclear factor-κB (NF-κB) pathway.

Results: IL-2 treatment induced a loss of cell viability in oral mucosa. Besides, inflammatory factors transcription and expression were significantly elevated in response to IL-2 treatment. In addition, oxidative stress and cell apoptosis were also augmented by IL-2 treatment. Mechanistically, IL-2 treatment was associated with an activation of the NF-ĸB pathway. Inhibition of NF-ĸB pathway could abolish the promotive effects exerted by IL-2 on oral mucosa death and inflammation response.

Conclusion: Taken together, our results demonstrated that IL-2 treatment activated NF-ĸB pathway and then promoted oral mucosa inflammation, leading to intracellular oxidative stress and cell apoptosis.

Disclosure statement

The authors have declared that they have no conflicts of interest.

Data availability statement

All data generated or analyzed during this study are included in this published article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.